2018
DOI: 10.1016/j.injury.2018.06.028
|View full text |Cite
|
Sign up to set email alerts
|

Hip fractures in the non-elderly—Who, why and whither?

Abstract: Nonelderly hip fracture patients have gathered little scientific attention, and our understanding of the group may be biased by patient case-mix and lack of follow-up. Preconceptions may thwart adequate investigation of bone health and other comorbidities. This literature review focusses on who these patients between 20 and 60 years are, how to treat them and how to evaluate the outcome. 2-11% of the hip fractures occur in non-elderly, equally common in men and women. Every second to forth patient smoke, have … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
44
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 64 publications
(46 citation statements)
references
References 61 publications
1
44
0
1
Order By: Relevance
“…The following protocol amendments were approved by the ethics committee (28 September 2018) and the Danish Medicines Agency (26 October 2018): The inclusion criterion age was changed from ≥ 65 years to ≥ 60 years. The cut ≥ 60 years is often used internationally when referring to elderly compared with nonelderly patients with hip fracture [59]. Further, patients from 60 to 64 years old would have the same potential benefit from the intervention.The exclusion criterion concerning PSA values was changed, so assessment of PSA is moved to the 3-week control, because a falsely elevated PSA value could be seen during admission due to urine catheterization.The exclusion criterion terminal illness was changed to active cancer or suspected pathological fracture .The time frame for baseline testing was changed from 6–10 days to 3–10 days due to short hospitalization for some patients.The intramuscular injection of trial medication was described to be administered in the gluteal muscle of the nonfractured leg.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The following protocol amendments were approved by the ethics committee (28 September 2018) and the Danish Medicines Agency (26 October 2018): The inclusion criterion age was changed from ≥ 65 years to ≥ 60 years. The cut ≥ 60 years is often used internationally when referring to elderly compared with nonelderly patients with hip fracture [59]. Further, patients from 60 to 64 years old would have the same potential benefit from the intervention.The exclusion criterion concerning PSA values was changed, so assessment of PSA is moved to the 3-week control, because a falsely elevated PSA value could be seen during admission due to urine catheterization.The exclusion criterion terminal illness was changed to active cancer or suspected pathological fracture .The time frame for baseline testing was changed from 6–10 days to 3–10 days due to short hospitalization for some patients.The intramuscular injection of trial medication was described to be administered in the gluteal muscle of the nonfractured leg.…”
Section: Methodsmentioning
confidence: 99%
“…The inclusion criterion age was changed from ≥ 65 years to ≥ 60 years. The cut ≥ 60 years is often used internationally when referring to elderly compared with nonelderly patients with hip fracture [59]. Further, patients from 60 to 64 years old would have the same potential benefit from the intervention.…”
Section: Methodsmentioning
confidence: 99%
“…In the early 1980 s, some centers expanded the indications to include the primary treatment of degenerative arthritis of the hip [4]. Although internal fixation would be the first alternative for femoral neck fracture in young patients, high reoperation rate after internal fixation and better patient-reported outcome after both THA and BHA with medium follow-up have been reported [5,6]. In proximal femur fractures such as femoral neck fractures with an intact acetabular cartilage, BHA remains an option that can be expected to be successful [7].…”
Section: Introductionmentioning
confidence: 99%
“…The literature on elderly patients older than 70 years with displaced FNFs is extensive and arthroplasty is clearly recommended as the treatment of choice [814]. The middle-aged patient group aged 55-70 years is less well described and the treatment for displaced FNFs is still controversial [11–13]. These patients are probably still working and demand a high level of activity.…”
Section: Introductionmentioning
confidence: 99%